| Description | SARS-CoV-2 Inactivated Virus Particles is chemically modifie to be non-infectious intact viral particles. The inactivation was verified in a standard microbiological growth protocol. Based on our in-house RT-PCR assay to detect the N proteins, it indicates that our product includes 1,000,000 copies SARS-CoV-2 Inactivated Virus Particles is chemically modifie to be non-infectious intact viral particles. The inactivation was verified in a standard microbiological growth protocol. Based on our in-house RT-PCR assay to detect the N proteins, it indicates that our product includes 1,000,000 copies per mL.... Read More | Cynomolgus monkey is widely used in medical experiments, especially those associated with neuroscience and disease. This product is isolated from tissue of Cynomolgus monkey. Cells are negative for bacteria, yeast, fungi, mycoplasma, and can be used for a variety of tests and assays such as cell-Cynomolgus monkey is widely used in medical experiments, especially those associated with neuroscience and disease. This product is isolated from tissue of Cynomolgus monkey. Cells are negative for bacteria, yeast, fungi, mycoplasma, and can be used for a variety of tests and assays such as cell-cell interaction, adhesion, migration, PCR, Western blot, immunoprecipitation, immunofluorescent staining, immunofluorescent flow cytometry, or generating cell derivatives for desired research applications.... Read More | This product is a 38.6 kDa Human GPR20 membrane protein expressed in HEK293. The protein is for research use only and is not approved for use in humans or in clinical diagnosis. | This product is a Mouse Gm11437 membrane protein expressed in vitro E.coli expression system. The protein is for research use only and is not approved for use in humans or in clinical diagnosis. | Recombinant O'nyong'nyong Virus-like Particles (ONNV VLPs) are produced in mammalian HEK293 human cells, assembled with E1, E2 and Capsid proteins. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material which makes themRecombinant O'nyong'nyong Virus-like Particles (ONNV VLPs) are produced in mammalian HEK293 human cells, assembled with E1, E2 and Capsid proteins. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material which makes them non-infectious, unable to replicate and enhance the safety during manufacture and administration. ONNV VLPs can be used in the development of ONNV diagnostics and in vaccine development and R&D (including use as an immunogen).... Read More |